Aclipse Therapeutics is focused on developing novel and highly differentiated drugs to address diseases with high unmet medical needs. Our strategy is reducing clinical development risk by combining a new and druggable understanding of disease pathways with a novel drug molecule that inhibits these pathways, allowing us to build upon existing nonclinical and clinical data while creating a significant patent barrier-to-entry.